NCT04965051: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM |
|
|
| Recruiting | N/A | 40 | RoW | insulin degludec/insulin aspart (IDegAsp), Ryzodeg, basal insulin plus pre-prandial insulin, Levemir/Lantus/Tresiba plus NovoLog/Humalog/Apidra | Second Affiliated Hospital, School of Medicine, Zhejiang University | Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range | 12/23 | 12/23 | | |
